Treatment of melanoma that has spread to other parts of the body using medications that help the immune system recognize and attack cancer cells by blocking checkpoint proteins that normally suppress immune responses.
Metastatic melanoma patients being considered for or receiving immunotherapy with checkpoint inhibitors.
"Patient will begin immunotherapy with checkpoint inhibitor (e.g., pembrolizumab, nivolumab, ipilimumab) per National Comprehensive Cancer Network (NCCN) guidelines for Stage IV melanoma."
This phrase is used when outlining the planned treatment approach for a patient with metastatic melanoma.
Common questions about using medical phrases in clinical documentation